HKEX Listing Rules allow biotech listings
New Rules for Listing Biotech Companies on the Hong Kong Stock Exchange
The Hong Kong Stock Exchange (the Exchange) published its Consultation Conclusions on a Listing Regime for Companies from Emerging and Innovative Sectors on 24 April 2018 (Consultation Conclusions) setting out Listing Rule changes which will allow the listing on the Exchange of two new categories of company – (i) pre-revenue biotech companies and (ii) innovative and high growth issuers which have weighted voting rights (WVR) structures. The new Rules take effect on 30 April 2018 and also create a new secondary listing route for innovative companies with primary listings on Qualifying Exchanges. Read more…